WVE logo

WVE
Wave Life Sciences Ltd

3,757
Mkt Cap
$1.37B
Volume
2.89M
52W High
$21.73
52W Low
$5.02
PE Ratio
-5.85
WVE Fundamentals
Price
$7.09
Prev Close
$7.28
Open
$7.22
50D MA
$12.28
Beta
1.57
Avg. Volume
5.91M
EPS (Annual)
-$1.21
P/B
2.57
Rev/Employee
$134,785.49
$2,290.62
Loading...
Loading...
News
all
press releases
WAVE Life Sciences Ltd. (NASDAQ:WVE) Receives Average Recommendation of "Moderate Buy" from Analysts
Shares of WAVE Life Sciences Ltd. (NASDAQ:WVE - Get Free Report) have received a consensus rating of "Moderate Buy" from the fifteen ratings firms that are currently covering the firm, MarketBeat...
MarketBeat·48m ago
News Placeholder
More News
News Placeholder
JPMorgan Chase & Co. Has $6.30 Million Position in WAVE Life Sciences Ltd. $WVE
JPMorgan Chase & Co. lessened its holdings in shares of WAVE Life Sciences Ltd. (NASDAQ:WVE - Free Report) by 45.2% in the third quarter, according to its most recent filing with the SEC. The firm...
MarketBeat·6d ago
News Placeholder
Wave Life Sciences (WVE) Surges 9.5%: Is This an Indication of Further Gains?
Wave Life Sciences (WVE) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Zacks·6d ago
News Placeholder
WAVE Life Sciences (NASDAQ:WVE) Shares Gap Up - Time to Buy?
WAVE Life Sciences (NASDAQ:WVE) Shares Gap Up - Here's What Happened...
MarketBeat·7d ago
News Placeholder
WAVE Life Sciences (NASDAQ:WVE) Stock Price Up 5.9% - Time to Buy?
WAVE Life Sciences (NASDAQ:WVE) Stock Price Up 5.9% - Time to Buy...
MarketBeat·11d ago
News Placeholder
WVE Posts Interim Data From Phase I Study on WVE-007, Stock Tanks
Wave Life Sciences stock plunges after interim phase I data for WVE-007 showed modest fat reduction at higher dose, despite some sustained benefits.
Zacks·11d ago
News Placeholder
Bank of America Has Lowered Expectations for WAVE Life Sciences (NASDAQ:WVE) Stock Price
Bank of America decreased their price target on WAVE Life Sciences from $38.00 to $21.00 and set a "buy" rating for the company in a research report on Friday...
MarketBeat·11d ago
News Placeholder
Wells Fargo & Company Cuts WAVE Life Sciences (NASDAQ:WVE) Price Target to $13.00
Wells Fargo & Company cut their price target on WAVE Life Sciences from $27.00 to $13.00 and set an "overweight" rating for the company in a research note on Friday...
MarketBeat·11d ago
News Placeholder
WAVE Life Sciences Shares Phase 1 WVE-007 Data Showing Visceral Fat Loss, Muscle Preservation Signal
WAVE Life Sciences (NASDAQ:WVE) highlighted positive interim data from the ongoing Phase 1 INLIGHT trial of WVE-007, a GalNAc-siRNA designed to treat obesity by improving body composition through fat...
MarketBeat·11d ago
News Placeholder
Stock Market Today, March 26: Wave Life Sciences Plunges After High Dose Obesity Drug Data Disappoints
Wave Life Sciences (NASDAQ:WVE), developer of RNA medicines for rare genetic diseases, closed Thursday at $6.20, down 49.59% for the session. The stock sank after disappointing higher-dose WVE-007...
Nasdaq News: Markets·11d ago
<
1
2
...
>

Latest WVE News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.